Selected Podcast

Is Medical Cannabis the New Epilepsy Treatment?

Medical cannabis has been used for years as an effective alternative to prescription pain medications. Now, new research and case studies have revealed medical cannabis can help with epilepsy treatment.

Epilepsy is a debilitating and sometimes fatal brain disorder that causes repetitive seizures. In some severe cases, you may experience several hundred seizures in a single day. Current treatments are only moderately effective and come with many harsh side effects, such as nausea, dizziness, weight loss, decreased appetite, inability to sleep, and, very rarely, liver failure.

AltMed's co-founder, Mike, has a daughter who suffered from epilepsy. One day, she was having a horrible seizure and needed to be rushed to a hospital with the presumption that she wasn't going to make it. She did manage to pull through and was heavily medicated on numerous pharmaceuticals but was put in a special school and told she wasn't going to live a normal life.

Mike got fed up with how the pharmaceuticals were making his daughter feel and sought a different type of treatment. Now that his daughter is healthy and happy, Mike sought out to start a company and produce a safe and effective treatment for others who are suffering from epilepsy.

Medical cannabis offers new hope for people suffering from epilepsy as a safe and effective alternative. In fact, a survey that appeared in the New England Journal of Medicine concluded 76 percent of doctors are in favor of using and recommending medical cannabis to their patients.

What are some ways patients are able to ingest medical cannabis?

There are many forms of medical cannabis that are used today. Other than smoking, many patients are incorporating the medical cannabis in food, oils, gum, and sprays.

What else do you need to know about medical cannabis?

AltMed's co-founder, David Wright, joins Dr. Mike to discuss why medical cannabis works as an effective treatment for certain illnesses and disease.
Is Medical Cannabis the New Epilepsy Treatment?
Featured Speaker:
DaveDavid Wright (AltMed President and CEO) has over 40 years of Pharmaceutical/Biotech experience in general management, manufacturing, market development, product launch, and commercial operations.

David served as President and Chief Executive Officer at Pharmathene Inc., President and Chief Operating Officer at Gen Vec, President and Chief Business Officer at Guilford Pharmaceuticals, and Executive Vice President for MedImmune Inc.

Additionally, David has held various Marketing and Sales positions at pharmaceutical companies including Smith Kline and French, G.D. Searle, and Glaxo. David has also served on the Board of Directors for Achillion Pharmaceuticals.